APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Checkpoint Inhibitors for Treating Cancer

Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include…

Types
PD-1 Inhibitors · PD-L1 Inhibitors · CTLA-4 Inhibitors
Applications
Melanoma Treatment · Bladder Cancer Treatment · Other

5 editions1 January 2026

View 5 research editions

Pharma & Healthcare

Paclitaxel

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Types
Natural Paclitaxel API · Semi-synthetic Paclitaxel API
Applications
Ovarian Cancer · Cervical Cancer · Breast Cancer

5 editions26 December 2025

View 5 research editions
$2,950Single user · USD · Industry ResearchExplore product: PaclitaxelCompare research options for Paclitaxel
APO Research, Inc.